Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Riveiro-Barciela

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Viral Hepatitis|December 2, 2016
Hepatitis C virus genotype 4: Genotype 1's little brotherJ Llaneras, M Riveiro-Barciela, M Buti, et al.
Journal of Viral Hepatitis|May 14, 2015
Therapy for hepatitis C genotype 3: moving forwardM Buti, J Llaneras, M Riveiro-Barciela, et al.
HIV Medicine|December 11, 2012
Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?F Fanjul, M Riveiro-Barciela, J Gonzalez, et al.
Transplantation Proceedings|December 17, 2011
Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case reportM Riveiro-Barciela, I Campos-Varela, J L Tovar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2017
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotypeM Riveiro-Barciela, M Bes, F Rodríguez-Frías, et al.
HIV Medicine|June 26, 2012
Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospitalM Riveiro-Barciela, V Falcó, J Burgos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 14, 2017
High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtypingF Rodriguez-Frias, L Nieto-Aponte, J Gregori, et al.
Journal of Viral Hepatitis|December 10, 2016
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohortS Alonso, M Riveiro-Barciela, I Fernandez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Viral Hepatitis|December 2, 2016
Hepatitis C virus genotype 4: Genotype 1's little brotherJ Llaneras, M Riveiro-Barciela, M Buti, et al.
Journal of Viral Hepatitis|May 14, 2015
Therapy for hepatitis C genotype 3: moving forwardM Buti, J Llaneras, M Riveiro-Barciela, et al.
HIV Medicine|December 11, 2012
Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?F Fanjul, M Riveiro-Barciela, J Gonzalez, et al.
Transplantation Proceedings|December 17, 2011
Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case reportM Riveiro-Barciela, I Campos-Varela, J L Tovar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2017
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotypeM Riveiro-Barciela, M Bes, F Rodríguez-Frías, et al.
HIV Medicine|June 26, 2012
Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospitalM Riveiro-Barciela, V Falcó, J Burgos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 14, 2017
High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtypingF Rodriguez-Frias, L Nieto-Aponte, J Gregori, et al.
Journal of Viral Hepatitis|December 10, 2016
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohortS Alonso, M Riveiro-Barciela, I Fernandez, et al.
Pageof 1